ANTIBODIES THAT NEUTRALIZE HEPATITIS B VIRUS AND USES THEREOF

AFFINITY PARTICLE, TEST REAGENT, AND DETECTION METHOD FOR DETECTING TARGET IMMUNOGLOBULIN G IN HUMAN SPECIMEN

METHOD FOR PRODUCING PARTICLE FOR IMMUNOASSAY FOR DETECTING ANTI-HBs ANTIBODY, AND PARTICLE OBTAINED BY THE PRODUCTION METHOD

METHOD FOR MEASURING GLYCOSYLATED SURFACE ANTIGEN PROTEIN OF HBV

ASSESSMENT AND TREATMENT OF CHRONIC HEPATITIS B

ANTI-RNA VIRUS PARTICLE ANTIBODY OF HBV

ANTI-HBV ANTIBODIES AND USES THEREOF

HBV DIAGNOSTIC, PROGNOSTIC, AND THERAPEUTIC METHODS AND PRODUCTS

ENGINEERING BACILLUS SUBTILIS AS A VERSATILE AND STABLE PLATFORM FOR PRODUCTION OF NANOBODIES

A METHOD TO MONITOR VIRUS-SPECIFIC T CELLS IN BIOLOGICAL SAMPLES

HEPATITIS E VIRUS ORF2 CAPSID POLYPEPTIDES AND USES THEREOF

SCREENING MODEL AND METHOD FOR HBV CCCDNA-TARGETING DRUG

RAA PRIMERS AND KITS FOR DETECTION OF HEPATITIS C VIRUS

ANTIBODY BINDING TO HEPATITIS B VIRUS SURFACE ANTIGEN AND APPLICATION OF ANTIBODY

KIT OF IN VITRO QUANTIFYING LARGE SURFACE PROTEIN OF HEPATITIS B VIRUS (HBV), BIOMARKER SET FOR ANALYZING PHASES OF HBV INFECTION AND HEPATOMA PROGNOSIS, AND SET OF MONOCLONAL ANTIBODIES FOR PREDICTING, DIAGNOSING OR TREATING CHRONIC LIVER DISEASE

EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES

LITHIUM HEPARIN AS A BLOCKING AGENT

Antibodies that neutralize hepatitis B virus and uses thereof

MHC Class I Associated Hepatitis B Peptides

Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection

Magnetic digital microfluidic apparatus and method of magnetic digital microfluidic manipulation

HEPATITIS E VIRUS ORF2 CAPSID POLYPEPTIDES AND USES THEREOF

Antibodies and fragments thereof that bind hepatitis B virus protein X

Multi-valent hepatitis B virus antigen binding molecules and uses thereof

Assay method and assay kit for hepatitis B virus S antigen

METHOD AND KIT FOR DETECTING HEPATITIS B SURFACE ANTIGEN

Exosome-mediated diagnosis of human immunodeficiency virus infection

Hepatitis E virus ORF2 capsid polypeptides and uses thereof

Exosome-mediated diagnosis of hepatitis virus infections and diseases

Antibodies and fragments thereof that bind hepatitis B virus protein X

VIRUS INFECTION MODEL, PREPARATION METHOD THEREFOR, AND UTILIZATION THEREOF

METABOLIC RESTRICTION IN CELL-BASED ASSAYS

Method and system for detection of disease agents in blood

MHC class I associated hepatitis B peptides

Tagged hepadnavirus E antigen and its use in screening antiviral substances

USE OF STING AGONISTS TO TREAT CHRONIC HEPATITIS B VIRUS INFECTION

Multi-valent hepatitis B virus antigen binding molecules and uses thereof

Method for producing antibody reagent

Polypeptides and antibodies for treating HBV infection and related diseases

RECOMBINANT HBV CCCDNA, THE METHOD TO GENERATE THEREOF AND THE USE THEREOF

Method and system for detection of disease agents in blood

Kit for measuring titer of a protein comprising human Fc using indirect ELISA and method for measuring titer of a protein comprising human Fc using the same

Test strip assembly comprising sample sorbent strip, flow separator, and reagent sorbent strip stacked on each other

Use of sting agonists to treat chronic hepatitis B virus infection

Antibody binding specifically to pre-S1 of hepatitis B virus and use of the antibody

Combo-Hepatitis Antigen Assays and Kits for Detection of Active Hepatitis Virus Infections

Tagged hepadnavirus e antigen and its use in screening antiviral substances

HBV epitope reactive exogenous T cell receptor (TCR) and uses thereof

Exosome-mediated diagnosis of hepatitis virus infections and diseases

Production of virus-receptive pluripotent stem cell (PSC)-derived hepatocytes

Compositions and methods for treating hepatitis B

Exosome-mediated diagnosis of hepatitis virus infections and diseases

LIVER INFECTION

MHC class I associated peptides for prevention and treatment of hepatitis B virus infection

Fluorescent-HAP: a diagnostic stain for HBV cores in cells

Use of sting agonists to treat hepatitis B virus infection

VIRUS-LIKE PARTICLE FOR USE IN IMMUNOASSAY, BLOCKING AGENT FOR USE IN THE IMMUNOASSAY, AND KIT COMPRISING THE VIRUS-LIKE PARTICLE AND THE BLOCKING AGENT

ANTIBODY DISPLAY

Pretreatment method of sample for detecting HBs antigen and use thereof

METHODS AND KITS FOR THE DETECTION OF VIRAL INFECTIONS

Development of HBV-and/or HDV-susceptible cells, cell lines and non-human animals

Polypeptides and antibodies for treating HBV infection and related diseases

Method for treating liver cancer

Human binding molecules capable of binding to and neutralizing hepatitis B viruses and uses thereof

HBV IMMUNOCOMPLEXES FOR RESPONSE PREDICTION AND THERAPY MONITORING OF CHRONIC HBV PATIENTS

Anti-HBc quantitative detection method and uses thereof in monitoring and controlling disease progression of chronic hepatitis B patient and in predicting therapeutic effect

Antibodies and method for determining deletions in HBV pre-S region

Multiplex method for detecting an infection

HBV CORE ANTIGEN PARTICLES WITH MULTIPLE IMMUNOGENIC COMPONENTS ATTACHED VIA PEPTIDE LIGANDS

Hepatitis B virus specific antibody and uses thereof

IP-10 BASED IMMUNOLOGICAL MONITORING

METHODS FOR DETECTION OR MEASUREMENT OF VIRUSES

Non-human animal disease mode for hepatitis B virus-associated disease

T-cell having a T-cell receptor that recognizes epitope HBC18-27 of hepatitis B viral core antigen

Surface antigen protein mutant of hepatitis B virus surface antigen

Electric analysis method

METHOD FOR SCREENING AN INHIBITORY AGENT OF HBV PROLIFERATION BY USING THE INTERACTION BETWEEN HBV CAPSID AND SURFACE PROTEINS BASED ON CELLULAR IMAGING

METHODS AND REAGENTS FOR VIRUS ISOLATION AND DETECTION

Multiplex Method for Detecting an Infection

IP-10 based immunological monitoring

Crystal structure of the catalytic domain of the viral restriction factor APOBEC3G

METHOD FOR DETECTING A VIRUS

Detection of primary infections with pathogens

Structure of the hepatitis C NS5A protein

Method of Detecting Carcinogenesis Caused by Hepatitis B Virus

HBV core antigen particles with multiple immunogenic components attached via peptide ligands

Sequence of reverse transcriptase gene and method of use

Hepatocellular carcinoma screening

Non-human mammal model comprising heterologous nucleated cells - use for screening compounds

Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof

Anti-HBs monoclonal antibody

Human hepatic progenitor cells and methods of use thereof

Viral variants and uses therefor

Antibodies against Nogo receptor

Biochip kit comprising biochip based on antigen-antibody reactions, and its usage

Single cell assessment of viral infection/replication

Hepatitis

Propagation of human hepatocytes in non-human animals